Genetic contribution to osteoarthritis development: Current state of evidence

Current Opinion in Rheumatology

Volumn 27, Issue 3, 2015, Pages 284-288

  Loughlin, John ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

ALDH1A2; DNA methylation; Genetic association; NCOA3; Single nucleotide polymorphism

Indexed keywords

ALDH1A2 GENE; ALLELE; CARTILAGE; CELL DIFFERENTIATION; DISEASE ACTIVITY; DNA METHYLATION; EPIGENETICS; GENE; GENE CONTROL; GENE EXPRESSION; GENE LOCUS; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; HOMEOSTASIS; HUMAN; NCOA3 GENE; OSTEOARTHRITIS; PRIORITY JOURNAL; REGULATOR GENE; REVIEW; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSCRIPTION REGULATION; GENETIC PREDISPOSITION; GENETICS; PROCEDURES;

GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; OSTEOARTHRITIS;

EID: 84926329234     PISSN: 10408711     EISSN: 15316963     Source Type: Journal    
DOI: 10.1097/BOR.0000000000000171     Document Type: Review

References (23)

1. arcOGEN Consortium, arcOGEN Collaborators, Zeggini E, et al. Identification of new susceptibility loci for osteoarthritis (arcOGEN): A genome-wide association study. Lancet 2012; 380:815-823.
2. Karlsson MK, Karlsson C, Magnusson H, et al. Individuals with primary osteoarthritis have different phenotypes depending on the affected joint: A case control study from southern Sweden including 514 participants. Open Orthop J 2014; 8:450-456.
3. Reynard LN, Loughlin J. Insights from human genetic studies into the pathways involved in osteoarthritis. Nat Rev Rheumatol 2013; 9:573-583.
4. Evangelou E, Kerkhof HJ, Styrkarsdottir U, et al. A meta-analysis of genomewide association studies identifies novel variants associated with osteoarthritis of the hip. Ann Rheum Dis 2014; 73:2130-2136.
5. Otsuki S, Taniguchi N, Grogan SP, et al. Expression of novel extracellular sulfatases Sulf-1 and Sulf-2 in normal and osteoarthritic articular cartilage. Arthritis Res Ther 2008; 10:R61.
6. Styrkarsdottir U, Thorleifsson G, Helgadottir HT, et al. Severe osteoarthritis of the hand associates with common variants within the ALDH1A2 gene and with rare variants at 1p31. Nat Genet 2014; 46:498-502.
7. Evans DS, Cailotto F, Parimi N, et al. Genome-wide association and functional studies identify a role for IGFBP3 in hip osteoarthritis. Ann Rheum Dis 2015 (in press).
8. Rodriguez-Fontenla C, Calaza M, Evangelou E, et al. Assessment of osteoarthritis candidate genes in a meta-analysis of 9 genome-wide association scans. Arthritis Rheumatol 2014; 66:940-949.
9. Reynard LN, Loughlin J. The genetics and functional analysis of primary osteoarthritis susceptibility. Expert Rev Mol Med 2013; 18:e2.
10. Barter MJ, Bui C, Young DA. Epigenetic mechanisms in cartilage and osteoarthritis: DNA methylation, histone modifications and microRNAs. Osteoarthritis Cartilage 2012; 20:339-349.
11. Ferná ndez-Tajes J, Soto-Hermida A, Vázquez-Mosquera ME, et al. Genomewide DNA methylation analysis of articular chondrocytes reveals a cluster of osteoarthritic patients. Ann Rheum Dis 2014; 73:668-677.
12. Rushton MD, Reynard LN, Barter MJ, et al. Characterization of the cartilage DNA methylome in knee and hip osteoarthritis. Arthritis Rheumatol 2014; 66:2450-2460.
13. Jeffries MA, Donica M, Baker LW, et al. Genome-wide DNA methylation study identifies significant epigenomic changes in osteoarthritic cartilage. Arthritis Rheumatol 2014; 66:2804-2815.
14. Moazedi-Fuerst FC, Hofner M, Gruber G, et al. Epigenetic differences in human cartilage between mild and severe OA. J Orthop Res 2014; 32:1636-1645.
15. den Hollander W, Ramos YFM, Bos SD, et al. Knee and hip articular cartilage have distinct epigenomic landscapes: implications for future cartilage regeneration approaches. Ann Rheum Dis 2014; 73:2208-2212.
16. Syddall CM, Reynard LN, Young DA, Loughlin J. The identification of transacting factors that regulate the expression of GDF5 via the osteoarthritis susceptibility SNP rs143383. PLoS Genet 2013; 9:e1003557.
17. Evangelou E, Chapman K, Meulenbelt I, et al. Large-scale analysis of association between GDF5 and FRZB variants and osteoarthritis of the hip, knee and hand. Arthritis Rheumatol 2009; 60:1710-1721.
18. Reynard LN, Bui C, Canty-Laird EG, et al. Expression of the osteoarthritisassociated gene GDF5 is modulated epigenetically by DNA methylation. Hum Mol Genet 2011; 20:3450-3460.
19. Reynard LN, Bui C, Syddall CM, Loughlin J. CpG methylation regulates allelic expression of GDF5 by modulating binding of SP1 and SP3 repressor proteins to the osteoarthritis susceptibility SNP rs143383. Hum Genet 2014; 133:1059-1073.
20. Meulenbelt I, Min JL, Bos S, et al. Identification of DIO2 as a new susceptibility locus for symptomatic osteoarthritis. Hum Mol Genet 2008; 17:1867-1875.
21. Bos SD, Bovee JV, Duijnisveld BJ, et al. Increased type II deiodinase protein in OA-affected cartilage and allelic imbalance ofOA risk polymorphism rs225014 at DIO2 in human OA joint tissues. Ann Rheum Dis 2012; 71:1254-1258.
22. Bomer N, den Hollander W, Ramos YF, et al. Underlying molecular mechanisms of DIO2 susceptibility in symptomatic osteoarthritis. Ann Rheum Dis 2015 (in press).
23. Panoutsopoulou K, Southam L, Elliott KS, et al. Insights into the genetic architecture of osteoarthritis from stage 1 of the arcOGEN study. Ann Rheum Dis 2011; 70:864-867.